CompletedNot Applicable

Transcorneal Electrical Stimulation Therapy for Retinal Disease

80 participantsStarted 2008-01

Plain-language summary

Transcorneal stimulation may enable neurons to survive degeneration processes via enhanced secretion of neurotrophic substances and direct stimulation of neurons.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Retinitis pigmentosa, Macula off, Primary open angle Glaucoma, Hereditary Macular Degeneration, Treated Retina detachment, Retinal Artery Occlusion, Retinal Vein Occlusion, Non-Arthritic-Anterior-Ischemic Optic-Neuropathy, Hereditary autosomal dominant Optic atrophy, dry Age-related Macular Degeneration, Ischemic Macula edema Exclusion Criteria: * Severe other disease such as non-proliferative diabetic retinopathy, exudative Age-related Macular Degeneration * Age above 99 years

What they're measuring

enhanced field of vision, enhanced visual acuity, lower threshold for electrical evoked phosphenes

Timeframe: 3 years

Trial details

NCT IDNCT00804102

SponsorOkuvision GmbH

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2011-04

View on ClinicalTrials.gov More Retinitis Pigmentosa trials